For patients with cancer requiring extended anticoagulant therapy, a strategy of reduced-dose apixaban was noninferior to full-dose apixaban for prevention of cancer-associated recurrent venous ...
On top of noninferior efficacy, the trial showed patients had less bleeding with 2.5 mg vs 5.0 mg twice daily over 12 months.
How the startup behind Cursor became the hottest, vibiest thing in AI• The Top 5: The lobbyists Silicon Valley loves to hire• ...
Looking for clues for today's Connections answers? The Connections answers on March 29 for puzzle #657 are harder than yesterday's puzzle, with the Connections Companion rating this puzzle's ...
21h
That’s the gist of my interview with Brian Ward, CEO of Saudi-owned Savvy Games Group, during the Game Developers Conference. Ward noted that Savvy-owned Scopely just announced its $3.5 billion ...
Baseball preview, 2025: NJSIAA group classifications, teams’ tourney competition Mar. 24, 2025, 10:51 a.m.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback